Senior insider sale
Chief Financial Officer at APOGEE THERAPEUTICS, INC. — senior position signals high conviction
$1.32M
18K shares
What this filing means
HENDERSON JANE plans to sell 18K shares of APOGEE THERAPEUTICS, INC. valued at approximately $1.32M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/25/2026ACC: 0001950047-26-002994
Officer· Chief Financial Officer
Since Mar 2026
18K
Shares to sell
$1.32M
Approx. market value
6K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Restricted Stock Award
N/A
2/1/2023
6KTotal acquired6K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/1/2023 | Restricted Stock Award N/A | 6K | — |
| Total | 6K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
2K
Market value
$140.4K
3/2/2026
—Completed
Units to sell
2K
Market value
$131.6K
2/2/2026
—Completed
Units to sell
2K
Market value
$160.0K
1/6/2026
—Completed
Units to sell
6K
Market value
$449.2K
1/2/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
6K
Market value
$438.0K
3/25/2026
Total
Units
18K
Value
$1.32M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/2/2026 | 2K | $140.4K | — | Completed |
2/2/2026 | 2K | $131.6K | — | Completed |
1/6/2026 | 2K | $160.0K | — | Completed |
1/2/2026 | 6K | $449.2K | — | Completed |
| Planned — Approximate Date | ||||
3/25/2026 | 6K | $438.0K | NASDAQ | Planned |
| Total | 18K | $1.32M | ||